Rational Prescribing in Primary Care (RaPP-trial). A randomised trial of a tailored intervention to improve prescribing of antihypertensive and cholesterol-lowering drugs in general practice [ISRCTN48751230]
- PMID: 12657163
- PMCID: PMC152643
- DOI: 10.1186/1472-6963-3-5
Rational Prescribing in Primary Care (RaPP-trial). A randomised trial of a tailored intervention to improve prescribing of antihypertensive and cholesterol-lowering drugs in general practice [ISRCTN48751230]
Abstract
Background: The underlying reasons for differences between clinical practice and systematically developed guidelines vary from one clinical problem to another. It is therefore logical to tailor strategies to support the implementation of guidelines to address identified barriers to change. The objective of this trial is to evaluate the effects of a tailored intervention to support the implementation of systematically developed guidelines for the use of antihypertensive and cholesterol-lowering drugs for the primary prevention of cardiovascular disease.
Methods/design: Unblinded, cluster-randomised trial. 150 general practices will be recruited from two geographical areas in Norway, and randomised to the intervention or control group (passive dissemination of guidelines). Outcomes will be measured for all eligible patients seen in the participating practices during one year after the intervention. A multifaceted intervention has been tailored to address identified barriers to change. Key components are an educational outreach visit with audit and feedback, and computerised reminders. Pharmacists will conduct the visits. During the outreach visit the main recommendations will be presented and software will be installed that links to the electronic medical record systems used in the participating practices. The software will perform an audit that will be fed back during the visit, present pop-up reminders for patients with high blood pressure or cholesterol, and provide a cardiovascular risk calculator and patient education material. The main outcomes are the proportions of 1) first time prescriptions for hypertension where thiazides are not prescribed, 2) patients not assessed for cardiovascular risk before prescribing antihypertensive or cholesterol-lowering drugs, and 3) patients treated for hypertension or high cholesterol for three months or more who have not achieved recommended treatment goals.
Figures


Similar articles
-
Rational prescribing in primary care (RaPP): a cluster randomized trial of a tailored intervention.PLoS Med. 2006 Jun;3(6):e134. doi: 10.1371/journal.pmed.0030134. PLoS Med. 2006. PMID: 16737346 Free PMC article. Clinical Trial.
-
Rational prescribing in primary care (RaPP): economic evaluation of an intervention to improve professional practice.PLoS Med. 2006 Jun;3(6):e216. doi: 10.1371/journal.pmed.0030216. PLoS Med. 2006. PMID: 16737349 Free PMC article.
-
Improving prescribing of antihypertensive and cholesterol-lowering drugs: a method for identifying and addressing barriers to change.BMC Health Serv Res. 2004 Sep 3;4(1):23. doi: 10.1186/1472-6963-4-23. BMC Health Serv Res. 2004. PMID: 15347426 Free PMC article. Clinical Trial.
-
The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.Can J Cardiol. 2010 May;26(5):249-58. doi: 10.1016/s0828-282x(10)70379-2. Can J Cardiol. 2010. PMID: 20485689 Free PMC article. Review.
-
Diuretics for cardiovascular prevention in the elderly.J Hum Hypertens. 2004 Dec;18 Suppl 2:S15-22. doi: 10.1038/sj.jhh.1001796. J Hum Hypertens. 2004. PMID: 15592568 Review.
Cited by
-
Effect of a workshop in rational pharmacotherapy for interns during family medicine clerkship in Samsun- Turkey.Pak J Med Sci. 2014 Mar;30(2):305-9. Pak J Med Sci. 2014. PMID: 24772132 Free PMC article.
-
Tailored interventions to overcome identified barriers to change: effects on professional practice and health care outcomes.Cochrane Database Syst Rev. 2010 Mar 17;(3):CD005470. doi: 10.1002/14651858.CD005470.pub2. Cochrane Database Syst Rev. 2010. Update in: Cochrane Database Syst Rev. 2015 Apr 29;(4):CD005470. doi: 10.1002/14651858.CD005470.pub3. PMID: 20238340 Free PMC article. Updated.
-
Tools developed and disseminated by guideline producers to promote the uptake of their guidelines.Cochrane Database Syst Rev. 2016 Aug 22;2016(8):CD010669. doi: 10.1002/14651858.CD010669.pub2. Cochrane Database Syst Rev. 2016. PMID: 27546228 Free PMC article.
-
A cluster randomized controlled trial of a clinical pathway for hospital treatment of heart failure: study design and population.BMC Health Serv Res. 2007 Nov 7;7:179. doi: 10.1186/1472-6963-7-179. BMC Health Serv Res. 2007. PMID: 17986361 Free PMC article. Clinical Trial.
-
Risk scoring for the primary prevention of cardiovascular disease.Cochrane Database Syst Rev. 2017 Mar 14;3(3):CD006887. doi: 10.1002/14651858.CD006887.pub4. Cochrane Database Syst Rev. 2017. PMID: 28290160 Free PMC article.
References
-
- WHO Collaborating Centre for Drug Statistics Methodology . Drug Consumption in Norway 1996 - 2000. In: Rønning M, editor. Oslo. Oslo; 2001.
-
- Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, Godwin J, Qizilbash N, Taylor JO, Hennekens CH. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 1990;335:827–838. doi: 10.1016/0140-6736(90)90944-Z. - DOI - PubMed
-
- Fretheim A, Williams JW, Oxman AD, Herrin J. The relation between methods and recommendations in clinical practice guidelines for hypertension and hyperlipidemia. The Journal of Family Practice. 2002;51:963–968. - PubMed
-
- Fretheim A, Bjørndal A, Oxman AD, Dyrdal A, Golding M, Ose L, Reikvam Å, Teisberg P. Guidelines for pharmacological primary prevention of cardiovascular disease: who should be treated? Tidsskr Nor Lægeforen. 2002;122:2277–2281. - PubMed
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical